#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2948	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2418	361.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1818	1818	T	428	T	396	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2948	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2418	361.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1552	1552	C	431	C,A,G	370,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2948	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2418	361.7	0	HET	.	.	.	A922G	.	922	922	A	1290	1290	A	447	A,G	301,95	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4926	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4159	354.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	2104	2104	A	406	A	355	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4926	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4159	354.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2738	2738	C	486	C	428	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4926	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4159	354.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2812	2812	A	507	A	447	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4926	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4159	354.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3364	3364	C	425	C,T	369,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	502	folP	852	852	99.88	folP.l15.c17.ctg.1	1876	80.2	0	.	p	.	0	P68S	NONSYN	202	204	CCG	711	713	TCG	112;112;111	T;C;G	103;104;103	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	502	folP	852	852	99.88	folP.l15.c17.ctg.1	1876	80.2	1	SNP	p	R228S	0	.	.	682	684	CGC	1191	1193	CGC	119;119;119	C,A;G;C	103,1;106;103	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1112	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3806	87.7	1	SNP	p	S91F	0	.	.	271	273	TCC	768	770	TCC	108;108;108	T;C;C	91;94;93	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1112	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3806	87.7	1	SNP	p	D95G	0	.	.	283	285	GAC	780	782	GAC	104;104;104	G;A;C	91;92;92	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1112	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3806	87.7	1	SNP	p	D95N	0	.	.	283	285	GAC	780	782	GAC	104;104;104	G;A;C	91;92;92	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	440	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1676	78.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	661	663	ACC	124;125;124	A;C;C	106;107;107	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	440	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1676	78.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	859	861	CAC	129;130;131	C;A;C	115;118;119	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	440	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1676	78.9	0	.	p	.	0	E117K	NONSYN	349	351	GAA	895	897	AAA	126;127;129	A;A;A	111;112;109	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	440	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1676	78.9	1	SNP	p	G45D	0	.	.	133	135	GGC	679	681	GGC	121;121;122	G;G,C;C	109;108,1;108	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	296	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1231	71.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	998	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3296	90.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1799	1801	GCA	120;120;120	G;C;A	106;107;107	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	998	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3296	90.8	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2282	2284	ATT	119;121;120	A;T;T	107;110;109	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	998	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3296	90.8	1	SNP	p	D86N	0	.	.	256	258	GAC	752	754	GAC	116;116;118	G;A;C	97;92;99	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	998	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3296	90.8	1	SNP	p	S87I	0	.	.	259	261	AGT	755	757	AGT	118;118;118	A;G;T	96;100;97	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	998	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3296	90.8	1	SNP	p	S87W	0	.	.	259	261	AGT	755	757	AGT	118;118;118	A;G;T	96;100;97	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	998	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3296	90.8	1	SNP	p	S87R	0	.	.	259	261	AGT	755	757	AGT	118;118;118	A;G;T	96;100;97	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	998	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3296	90.8	1	SNP	p	S88P	0	.	.	262	264	TCC	758	760	TCC	116;115;116	T;C;C	95;95;99	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	912	parE	1986	1986	99.9	parE.l15.c4.ctg.1	2972	92.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1723	1725	GGC	128;127;127	G;G;C	113;112;112	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.002	penA.22.002	1	1	27	722	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2944	73.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1383	1385	GCA	107;106;106	G;C;A	90;91;93	penA.22.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	722	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2944	73.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1386	1388	ATC	106;106;106	A;T;C	93;89;92	penA.22.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	722	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2944	73.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1398	1400	GTG	110;110;110	G;T;G	92;89;91	penA.22.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	722	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2944	73.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1398	1400	GTG	110;110;110	G;T;G	92;89;91	penA.22.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	722	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2944	73.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1902	1904	ACC	104;104;104	A;C;C	90;90;93	penA.22.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	722	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2944	73.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1956	1958	GCG	99;99;98	G;C;G	82;79;77	penA.22.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	722	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2944	73.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1956	1958	GCG	99;99;98	G;C;G	82;79;77	penA.22.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	722	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2944	73.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2079	2081	GGT	93;94;94	G,T;G;T	77,1;81;81	penA.22.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	722	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2944	73.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2088	2090	GGC	96;98;98	G,A,T;G;C	79,1,1;82;82	penA.22.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.002	penA.22.002	1	1	27	722	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2944	73.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2106	2108	CCG	99;99;99	C;C;G	79;81;80	penA.22.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1042	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3402	91.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1736	1738	CTG	104;103;104	C;T;G	87;87;86	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	570	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2119	80.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	724	724	C	95	C	84	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	584	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1957	87.5	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	863	865	CAA	128;128;128	C;A,T;A	114;112,1;115	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	584	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1957	87.5	0	.	p	.	0	E212G	NONSYN	634	636	GAA	1070	1072	GGT	110;109;109	G;G;T	95;92;90	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	584	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1957	87.5	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1073	1075	GAT	108;106;106	G;A;T	93;93;92	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	584	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1957	87.5	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1088	1090	ATG	108;108;108	A;T;G	97;96;98	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	584	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1957	87.5	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1205	1207	AAG	125;124;125	A,C;A;G	111,1;109;110	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	584	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1957	87.5	1	SNP	p	G120K	0	.	.	358	360	GGC	794	796	GGC	126;126;126	G;G;C	108;110;109	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2010	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5204	115.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2178	2180	CAT	112;110;111	C;A;T	94;89;95	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	312	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1324	70.7	1	SNP	p	V57M	0	.	.	169	171	GTG	685	687	GTG	127;126;126	G;T,G;G	104;103,1;104	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
